Edition:
United States

Enzo Biochem Inc (ENZ)

ENZ on New York Consolidated

9.05USD
23 May 2017
Change (% chg)

$0.11 (+1.23%)
Prev Close
$8.94
Open
$8.99
Day's High
$9.16
Day's Low
$8.93
Volume
81,799
Avg. Vol
217,007
52-wk High
$9.68
52-wk Low
$4.88

Latest Key Developments (Source: Significant Developments)

Enzo Biochem Qtrly loss per share $0.03
Thursday, 8 Dec 2016 04:05pm EST 

Enzo Biochem Inc : Qtrly loss per share $0.03 . Enzo Biochem reports improved first quarter results .Q1 revenue rose 4 percent to $26.3 million.  Full Article

Enzo Biochem announces New York State Health Department approval of new cardiac assay
Tuesday, 20 Sep 2016 12:24pm EDT 

Enzo Biochem Inc : Enzo Biochem announces New York State Health Department approval of new easily adaptable, cost effective cardiac assay .New York State Department of Health has granted conditional approval for use of Enzo Clinical Labs' PLAQPRO(tm) Lp-PLA2Assay.  Full Article

Enzo Biochem files for mixed shelf of up to $50 mln
Thursday, 1 Sep 2016 05:39pm EDT 

Enzo Biochem Inc : Files for mixed shelf of up to $50 million - SEC filing Source: (http://bit.ly/2cd7ICi) Further company coverage: [ENZ.N] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Enzo Biochem says Enzo Life Sciences reached settlement with Illumina that included payment of $21 mln to Enzo
Thursday, 7 Jul 2016 08:01am EDT 

Enzo Biochem Inc : Co's unit, Enzo Life Sciences, has reached and finalized a settlement with Illumina that included a payment of $21 million to enzo . Settlement resolving dispute between Enzo Life Sciences and Illumina impacts only one of 11 cases originally brought by enzo .Settlement related to action brought in delaware court by Enzo alleging infringement of patent.  Full Article

Enzo Biochem Q3 non-gaap loss per share $0.04
Wednesday, 8 Jun 2016 07:30am EDT 

Enzo Biochem Inc : Enzo Biochem reports fiscal third quarter results . Q3 non-gaap loss per share $0.04 . Q3 loss per share $0.05 .Q3 revenue rose 10 percent to $26.4 million.  Full Article

Enzo Biochem reaches settlement with unit of Thermo Fisher
Monday, 16 May 2016 04:07pm EDT 

Enzo Biochem Inc : Settlement does not affect unit's action brought in federal district court in new haven, ct against life technologies' predecessors . Settlement resolves dispute between enzo life sciences and life technologies impacts only one of 11 cases originally brought by enzo . Resolved suit is one of 11 infringement cases brought in delaware federal district court; seven remain pending .Enzo biochem's life sciences unit reaches $35 million patent infringement settlement in delaware with life technologies corporation.  Full Article

Enzo Biochem Inc reaches $9 million patent infringement settlement with Agilent Technologies Inc
Wednesday, 6 Jan 2016 08:30am EST 

Enzo Biochem Inc:Has reached and finalized a settlement with Agilent Technologies Inc payment of $9 million to Enzo in an infringement action brought by Enzo regarding its U.S. Patent No. 7,064,197.Says resolved suit involves one of 11 infringement cases brought in delaware federal district court, eight of which remain pending.  Full Article

Enzo Biochem Inc reaches $10 million patent infringement settlement with Affymetrix Inc
Tuesday, 13 Oct 2015 08:00am EDT 

Enzo Biochem Inc:Reached and finalized a settlement with Affymetrix Inc involving payment of $10 million to Enzo in an infringement action brought by Enzo regarding U.S. Patent No. 7,064,197.Settlement resolving disputes between Enzo and Affymetrix impacts only one of 11 cases originally brought by Enzo in the United States District Court for the District of Delaware.  Full Article

Enzo Biochem Reaches $7.1 Million Patent Infringement Settlement with Luminex Corporation
Monday, 6 Jul 2015 10:00am EDT 

Enzo Biochem:Reached and finalized a settlement with Luminex Corporation involving payment of $7.1 million to Enzo in an infringement action brought by Enzo regarding its U.S. Patents Nos. 6,992,180; 7,064,197; and 8,097,405.Resolved suit involves one of 12 infringement cases brought in delaware federal district court, rest of which remain pending.  Full Article

More From Around the Web

BRIEF-Enzo Biochem Q2 non-gaap loss per share $0.02

* Enzo Biochem reports increased second quarter operating results